Alethea Capital Management, LLC Astrazeneca PLC Transaction History

Alethea Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $866,669 - $1.08 Million	-17,899 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $844,116 - $974,421	17,899 New	17,899 $890,000
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $940,366 - $1.12 Million	-19,381 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $1.03 Million - $1.18 Million	19,381 New	19,381 $1.06 Million
Q2 2019 Aug 12, 2019	SELL	$37.28 - $41.68 $897,478 - $1 Million	-24,074 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$35.49 - $43.02 $854,386 - $1.04 Million	24,074 New	24,074 $973,000
Q4 2018 Jan 23, 2019	SELL	$36.86 - $41.49 $721,239 - $811,834	-19,567 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$34.76 - $39.72 $680,148 - $777,201	19,567 New	19,567 $774,000

1,358

512M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $234B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Alethea Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alethea Capital Management, LLC with notifications on news.